BTS Bioengineering

Garbagnate Milanese, Italy Founded: 1986 • Age: 40 yrs
Motion capture systems are supplied for sports and healthcare applications.

About BTS Bioengineering

BTS Bioengineering is a Healthcare company based in Garbagnate Milanese (Italy) founded in 1986. It operates as a motion capture systems are supplied for sports and healthcare applications. Its website btsbioengineering.com draws about 15 thousand monthly visits. BTS Bioengineering offers products and services including SMART-DX, EVO, FREEEMG, G-WALK, and BTS GAITLAB. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is BTS S.p.A. Its competitors include Blackrock Neurotech, Nexstim, MindMaze, Precision Neuroscience and INBRAIN Neuroelectronics and 4 more; 8 of its 9 listed competitors have raised funding.

Company details

Founded in 1986 in Garbagnate Milanese, Italy, operations in bioengineering focus on motion capture technology for sports and healthcare sectors. Integrated tools are developed for motor and neurological rehabilitation among adults and children. Systems for motion analysis are applied to support athlete performance. Key areas encompass gait and posture evaluation, sport biomechanics, ergonomics, and programs for cognitive rehabilitation, mobility, injury prevention, and return-to-play protocols.

  • Headquarters Garbagnate Milanese, Italy
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website btsbioengineering.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Bts S.P.A.
Operational Areas
Key Metrics

Products & Services of BTS Bioengineering

BTS Bioengineering offers a comprehensive portfolio of products and services, including SMART-DX, EVO, FREEEMG, G-WALK, and BTS GAITLAB.

SMART-DX
Motion Capture System

Captures human body movements for engineering and research applications.

EVO
Motion Capture System

Supports motion analysis in medical and sports contexts.

FREEEMG
Electromyography Tool

Evaluates muscle activity for rehabilitation and performance.

G-WALK
Gait Analysis System

Assesses walking patterns in clinical and sports settings.

BTS GAITLAB
Integrated Solution

Provides comprehensive gait evaluation for medical diagnostics.

Apps and channels of BTS Bioengineering

its YouTube channel BTS Bioengineering has 1.74K subscribers and 30 videos.

BTS Bioengineering
YouTube 1.74K subscribers 30 videos Science & Technology
Open channel

Videos from BTS Bioengineering

The most watched videos on BTS Bioengineering's YouTube channel, BTS Bioengineering (1.74K subscribers). Click a video to play it here.

NIRVANA3 | What's new in Nirvana 3.0
834 views
FREELAB TRAINING - The drop fall protocol
732 views
BTS SPORTLAB Training - The new Jump Protocols Package
644 views
BTS PODIUM TRAINING New updated real time analysis
592 views

More on BTS Bioengineering.

Funding Insights of BTS Bioengineering

  • Total Rounds 1
  • Last Round Grant β€” $144,599
  • First Round $144,599

    (Feb 2021)

  • Investors Count 1

All 1 funding rounds of BTS Bioengineering with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2021$144,599Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in BTS Bioengineering

BTS Bioengineering has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for BTS Bioengineering

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of BTS Bioengineering

2 dated milestones of BTS Bioengineering across 35 years, from founding to its latest funding, stage changes and deals.

  1. Founded BTS Bioengineering is founded.
  2. Funding First funding round of $145K.

Competitors of BTS Bioengineering

BTS Bioengineering has 9 listed competitors in our database, 8 of them funded. They include Blackrock Neurotech, Nexstim, MindMaze, Precision Neuroscience and INBRAIN Neuroelectronics, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
blackrockneurotech.com2008Salt Lake, United States$22.37M127
Medical devices for neurological therapies are developed.
nexstim.com2000Helsinki, Finland$29.67M–
Noninvasive brain stimulation is provided for stroke patient rehabilitation.
mindmaze.com2012Lausanne, Switzerland$223.5M–
Evidence-based digital neurotherapeutics are developed for brain health recovery.
precisionneuro.io2021New York, United States$182.65M22
Brain-computer interfaces developed for medical treatment and drug development.
inbrain-neuroelectronics.com2019Barcelona, Spain$82.84M–
AI-based neuroelectronic devices for brain disorder detection are developed.
synergia-medical.com2013Mont Saint Guibert, Belgium$14.16M18
Implantable neurostimulators and contactless monitoring systems are developed.
endonovo.com2011Los Angeles, United States––
Bioelectronic devices are developed for regenerative medicine therapies.
minnetronixmedical.com1996Saint Paul, United States$20M263
Multiple devices for neurocritical patients are manufactured and developed.
heliusmedical.com2014Newtown Square, United States$391,09226
Neurological rehabilitation devices are developed for brain healing amplification.
Premium access

Detailed competitors of BTS Bioengineering

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of BTS Bioengineering

The website of BTS Bioengineering (btsbioengineering.com) receives about 15.5K visits a month.

  • Monthly visits
    15.5K

    ▲ 22.2% vs previous month

Similar websites

Websites whose visitors overlap most with BTS Bioengineering. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ergoline.com
100%
2.7K#5,868,269View details
fda.gov
86%
–#7,606View details
cosmed.it
cosmed.it
66%
–––
c-motion.com
37%
––View details
basketballtrainer.com
basketballtrainer.com
32%
–#15,234,237–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 7 similar websites and full traffic analytics for BTS Bioengineering

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Neurology

10 companies that operate in the same segment as BTS Bioengineering (Neurology), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Novel biopharmaceutical medicines are developed for unmet medical needs.
2003Dublin, IrelandUSD 265 MUSD 4.27 B2,800
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
2013San Francisco, California, United StatesUSD 214.78 MUSD 21.05 M211
Developer of therapeutics for psychiatric and neurologic diseases
2002New York, New York, United StatesUSD 80.87 MUSD 250.31 M600
Biologics platform developed for intracellular delivery in rare diseases.
2016Boston, Massachusetts, United StatesUSD 175.25 MUSD 25.42 M183
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
MR-interfaced ultrasound devices for cancer and neurology treatments are provided.
1999Tirat Carmel, Haifa District, IsraelUSD 574.2 M––
AI-driven drug discovery platform for neurological diseases based on patients biomarkers
2019San Francisco, California, United StatesUSD 144.72 M–76
Small molecule drugs for rare diseases are developed.
1998South Plainfield, New Jersey, United StatesUSD 248.1 MUSD 1.73 B939
Developer of small molecule therapeutics for endocrine and CNS disorders
1992San Diego, California, United StatesUSD 10 MUSD 2.86 B1,800
Developer of antibodies to treat complement-mediated neurodegenerative diseases
2011San Francisco, California, United StatesUSD 256 M–100
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about BTS Bioengineering

BTS Bioengineering was founded in 1986 and raised its 1st funding round 35 years after it was founded.

BTS Bioengineering is headquartered in Garbagnate Milanese, Italy. It is registered at Garbagnate Milanese, Lombardy, Italy.

Founded in 1986 in Garbagnate Milanese, Italy, operations in bioengineering focus on motion capture technology for sports and healthcare sectors. Integrated tools are developed for motor and neurological rehabilitation among adults and children. Systems for motion analysis are applied to support athlete performance. Key areas encompass gait and posture evaluation, sport biomechanics, ergonomics, and programs for cognitive rehabilitation, mobility, injury prevention, and return-to-play protocols.

BTS Bioengineering's top competitors include Blackrock Neurotech, Precision Neuroscience and INBRAIN Neuroelectronics.

BTS Bioengineering offers SMART-DX, EVO, FREEEMG, G-WALK, and BTS GAITLAB.

BTS Bioengineering has 1 investor. Key investors include European Union.

BTS Bioengineering operates through Bts S.P.A..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available